Drexel Hamilton Starts Embraer (ERJ) at Buy; Defense & BizJets Give Thrust
Tweet Send to a FriendGet Alerts ERJ Hot Sheet
Price: $37.94 -1.66%
Rating Summary:
9 Buy, 5 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Rating Summary:
9 Buy, 5 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Trade ERJ Now!
Drexel Hamilton initiates coverage on Embraer (NYSE: ERJ) with a Buy. PT $33.00.
Analyst, Peter Skibitski, said, "We see the main growth drivers for ERJ over the next few years as its Defense and Executive Aviation segments, which have leverage to increased Brazilian defense projects and new greenfield business jets that should take share...As well, the planned Brazilian INSS Social Security payroll tax cut offers leverage to revenue growth. While we think the tax cut only impacts 2012 operating margin by ~30 bps, for 2013 and 2014 we estimate the impact at 110 and 120 bps, respectively."
For an analyst ratings summary and ratings history on Embraer click here. For more ratings news on Embraer click here.
Shares of Embraer closed at $29.29 yesterday, with a 52 week range of $20.98-$35.55.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Peter Skibitski, said, "We see the main growth drivers for ERJ over the next few years as its Defense and Executive Aviation segments, which have leverage to increased Brazilian defense projects and new greenfield business jets that should take share...As well, the planned Brazilian INSS Social Security payroll tax cut offers leverage to revenue growth. While we think the tax cut only impacts 2012 operating margin by ~30 bps, for 2013 and 2014 we estimate the impact at 110 and 120 bps, respectively."
For an analyst ratings summary and ratings history on Embraer click here. For more ratings news on Embraer click here.
Shares of Embraer closed at $29.29 yesterday, with a 52 week range of $20.98-$35.55.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Keryx Biopharma (KERX) Patents Strong; JPMorgan Starts at Overweight
- Maxim Group Starts Agenus (AGEN) at Buy, PT $19
- Morgan Stanley Starts MasterCard (MA) at Overweight
Create E-mail Alert Related Categories
New Coverage
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
